Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

JK Cement - Ripe for re-rating - ICICI Securities

Posted On: 2020-07-05 21:56:34


JK Cement's (JKCE) recent capacity additions in high utilisation / better pricing markets of North / Central regions are likely to see a quick ramp-up along with better cost efficiencies. Consolidated net debt is likely to peak out at Rs24bn in FY21E as JKCE could generate OCF of >Rs10bn p.a. from FY22E which would be sufficient for its future capex requirements. Besides, JKCE enjoys better than peers' RoEs of 16-18% over FY20-22E. Factoring higher utilisation, we raise our FY22E EBITDA / EPS by 4-6%. With improving growth / market share and profitability, we raise our target multiple to 10x (earlier 9x) and increase our target price to Rs1,725/share (earlier: Rs1,460) based on 10x FY22E EV/E. Maintain BUY.

- Key triggers for re-rating: Quick ramp-up of new capacities (better volume growth), improved cost efficiencies resulting in grey cement EBITDA/te sustaining above Rs1,000/te, peaking-out of consolidated net debt in FY21.

- Key risks to re-rating: Any pricing weakness in JKCE's key markets of North, increased investments / losses in UAE subsidiaries, higher pay outs to consultants, lower growth / profitability in white cement portfolio.

- Capacity expansion benefits to kick in: JKCE commissioned 2.6mnte clinker unit at Mangrol and 3.5mnte grinding capacities at Mangrol and Aligarh in H2FY20. Given that new capacity additions are in high growth / utilisation markets of North and Central regions, they may see a quick ramp up, in our view. Besides, pricing is expected to remain firm in these regions as utilisation remains at >80% owing to better supply / demand dynamics. Commissioning of 0.7mnte grinding unit at Balasinor is likely by Oct'20, while modernisation of 0.3mnte line-3 at Nimbahera is expected to complete by Dec'20.

- Cost savings of Rs100/te possible over the next two years on the back of better cost efficiencies from new capacity at Mangrol and modernisation of line-3 at Nimbahera in FY21. Besides, the management is targeting fixed-cost reduction of Rs600mn-700mn in FY21, which includes ~25% YoY cut in professional charges. Grey cement EBITDA/te is likely to increase to Rs1,065/te by FY22E from ~Rs940/te (our estimate) in FY20.

- Consolidated net debt likely to peak out at Rs24bn in FY21E: JKCE would incur capex of Rs4bn for ongoing expansion projects and Rs2.5bn for line-3 Nimbahera modernisation in FY21. Net debt to EBITDA ratio may decline from 1.9x in FY20 to 1.3x in FY22E. JKCE is likely to generate OCF of >Rs10bn p.a. from FY22E which would be sufficient for its future capex requirements. JKCE also enjoys better than peers' RoEs of 16-18% over FY20-22E. The stock trades at an attractive valuation of 8.4xFY22E EV/E.

Shares of J.K.CEMENT LTD. was last trading in BSE at Rs.1416 as compared to the previous close of Rs. 1393.5. The total number of shares traded during the day was 778 in over 168 trades.

The stock hit an intraday high of Rs. 1424 and intraday low of 1391.65. The net turnover during the day was Rs. 1098078.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Cadila Healthcare - Q1FY21 First Cut - ICICI Securities

Dwarikesh Sugar - Q1FY21 First Cut - ICICI Securities

Jyothy Lab - Q1FY21 First Cut - ICICI Securities

Avenue Supermarts - Company Update - August 2020 - ICICI Securities

Hawkins Cookers - 1QFY21 Results - Angel Broking

Maintain REDUCE on Godrej Consumers - Strong comeback in H1 - HDFC Securities

ADD on Gujarat Gas - A complete washout quarter - HDFC Securities

SELL on Vinati Organics - At an inflexion point - HDFC Securities

Expectations from the upcoming RBI Policy - HDFC Securities

AXIS Bank - 10,000 Cr QIP - Angel Broking

PI Industries - Mr. Jyoti Roy, DVP - Equity Strategist, Angel Broking Ltd.

Maintain BUY on Teamlease Services - Recovery on the cards ICICI Securities

Reiterate ADD on Tata Motors - Volatile environment - ICICI Securities

Tata Consumer Products Ltd - 1QFY21 results - Rajit Rajoriya, Equity Research Associate, Angel Broking Ltd

Maintain REDUCE On Karur Vysya Bank - Pain inevitable - HDFC Securities

Sovereign Gold Bonds - Thematic Report - ICICI Securities

Varun Beverages - Q2CY20 Result Update - ICICI Securities

Saregama India - Company Update - August 2020 - ICICI Securities

Exide Industries - Q1FY21 Result Update - ICICI Securities

Indian Oil Corporation - Q1FY21 Result Update - ICICI Securities

Maintain ADD on Indian Oil Corporation - High inventory losses drag earnings - HDFC Securities

Maintain BUY on Cholamandalam Investment & Finance - A mostly good show - HDFC Securities

Maintain ADD on BSE - Fighting its way back - HDFC Securities

Maintain ADD on Motilal Oswal Financial Services - In-line performance - HDFC Securities

Maintain BUY on Sobha - A smooth ride with few bumps - HDFC Securities

Banking Sector Credit Trends Report - Growth slows, as expected - HDFC Securities

Maintain ADD on Sun Pharma - Cost savings drive the quarterly beat - HDFC Securities

Auto Sector Performance - July'20 - Angel Broking

Sector Thematic on Indian Gas Sector - Looking beyond the pandemic - HDFC Securities

ADD on Max Financial - Lower margins despite higher protection - HDFC Securities

Maintain BUY on Mastek - Changing orbit - HDFC Securities

Mantain REDUCE On Dabur - In-line 2Q, slight beat in domestic volume - HDFC Securities

CreditAccess Grameen - Q1FY21 - YES Securities

ADD on Torrent Pharma - Resilient performance - HDFC Securities

BSE Limited - Pricing pressure remains a challenge - ICICI Securities

Kansai Nerolac Paints - Better-than-expected trajectory in decorative paints -

VA Tech Wabag - High receivables, low margins to impact earnings - ICICI Securities

CreditAccess Grameen - Customer activation trend shows resilience - ICICI Securities

Tata Chemicals - Q1FY21 Result Update - ICICI Securities

VST Industries - Q1FY21 Result Update - ICICI Securities

ADD on Navin Fluorine International - Commendable performance - HDFC Securities

Whirlpool of India - Valuations belie outlook; risk-reward unfavourable - ICICI Securities

Kansai Nerolac - Q1FY21 First Cut - ICICI Securities

Exide Industries - Q1FY21 First Cut - ICICI Securities

Monthly Auto Volumes - July, 2020 - ICICI Securities

Cholamandalam Investments and Finance Company Ltd - Q1FY21 Result Update - YES Securities

Mahindra logistics - Q1FY21 Result Update - YES Securities

Bluedart Express - Q1FY21 Result Update - YES Securities

Tata Motors - Cost improvements reassuring - ICICI Securities

Godrej Agrovet - Deflation in input prices leads to higher margin - ICICI Securities







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019